A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed
Clinical trial NCT00097019 · COMPLETED
Trial details
- NCT number
- NCT00097019
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2006-05-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.